Blood levels of histamine, IL-1β, and TNF-α in patients with mild to moderate alzheimer disease

Alvarez, X. Antón, Franco, Andrés, Fernández-Novoa, Lucía, Cacabelos, Ramón·1996·Molecular and Chemical Neuropathology
DOI 10.1007/bf02815005

Cited by (139)

Items 101–139 of 139

  1. CanToxoplasma gondiiPave the Road for Dementia?
    Enas Aly El Saftawy, Noha Mohamed Afifi Amin, Rania Mohamed Sabry, Noha El‐Anwar, Rania Y. Shash, Eman Hany Elsebaie, Rita Maher Wassef · 2020 · Journal of Parasitology Research
  2. Increased serum neopterin levels in adults with Down syndrome
    Pankaj D Mehta, Bruce A. Patrick, Arthur J. Dalton, Bindu N. Patel, Sangita P. Mehta, Tuula Pirttilä, Patricia Katherine Coyle · 2005 · Journal of Neuroimmunology
  3. The Role of Probiotics in Modulating the Gut Microbiome in Alzheimer’s Disease: A Review
    Yushi Dong, Xilin Wu, Yumeng Zhang, Adi Hu, Qian Zhou, Xiqing Yue, Zhenmin Liu, Mohan Li · 2025 · Foods
  4. Recent advances in pre-clinical diagnosis of Alzheimer’s disease
    John Zhou, Marc Benoit, Md Golam Sharoar · 2021 · Metabolic Brain Disease
  5. Impairment in the aversive memory of mice in the inhibitory avoidance task but not in the elevated plus maze through intra-amygdala injections of histamine.
    F. Daher, R. Mattioli · 2015 · Pharmacology, Biochemistry and Behavior
  6. Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation
    Marina Saresella, C Zoia, Francesca La Rosa, Chiara Bazzini, Gessica Sala, Erica Grassenis, Ivana Marventano, Ambra Hernis, Federica Piancone, Elisa Conti et al. · 2023 · Pharmaceuticals
  7. Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease
    Aidonio Fiolaki, Konstantinos Ioannis Tsamis, Haralampos J. Milionis, Athanassios P. Kyritsis, Maria S. Kosmidou, Sotirios Giannopoulos · 2013 · International Journal of Neuroscience
  8. No association between histamine N-methyltransferase functional polymorphism Thr105Ile and Alzheimer's disease
    Ivana Marasović Šušnjara, Vinko Palada, Ivana Marinovic‐Terzić, Ninoslav Mimica, Josipa Marin Lovrić, Dorotea Mück‐Šeler, Maja Mustapić, Paola Presečki, Nela Pivac, Vera Folnegović-Šmalc et al. · 2010 · Neuroscience Letters
  9. Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer’s Disease
    Eunice D. Farfán‐García, Ricardo Márquez-Gómez, Mónica Barrón‐González, Teresa Pérez‐Capistran, Martha Cecilia Rosales‐Hernández, Rodolfo Pinto‐Almazán, Marvin Antonio Soriano-Ursua · 2019 · Current Alzheimer Research
  10. Anapsos: Neuroimmunotrophic Treatment in Alzheimer Disease and Neurodegenerative Disorders
    Antón Álvarez, José Javier Miguel-Hidalgo, L. Fernández‐Novoa, Joaquín Díaz, Jose Miguel Sempere, Ramón Cacabelos · 1997 · CNS Drug Reviews
  11. Does the Insulin-Like Growth Factor System Interact with Prostaglandins and Proinflammatory Cytokines During Neurodegeneration?
    Brett R. Lackey, Sandra L. Gray, Donald M. Henricks · 2000 · Proceedings of The Society for Experimental Biology and Medicine
  12. Recent advances in Alzheimer’s disease pathogenesis and therapeutics from an immune perspective
    Thai-Duong Nguyen, Loi Nguyen Dang, Jung-hee Jang, Soyeun Park · 2023 · Journal of Pharmaceutical Investigation
  13. Cerebrovascular Changes Associated with Interleukin‐1β (IL‐1β) and Histamine (HA) Levels in Alzheimer's Disease
    X. Anton Alvarez, L. Fernández‐Novoa, José Carlos Caamaño, Lola Corzo, Raquel Zas, Katrin Beyer, José I. Lao, Ramón Cacabelos · 1997 · Annals of the New York Academy of Sciences
  14. The Role of the Immune System in Alzheimer's Disease
    Robert M. Cohen · 2009 · FOCUS The Journal of Lifelong Learning in Psychiatry
  15. Genomics of immune molecules: early detection of cognitive decline and new therapeutic interventions
    Federico Licastro · 2002 · Expert Review of Neurotherapeutics
  16. Reduced susceptibility to Kainic Acid-induced excitoxicity in T-cell deficient CD4/CD8(−/−) and middle-aged C57BL/6 mice
    Zhiguo Chen, Hans‐Gustaf Ljunggren, Shunwei Zhu, Bengt G. Winblad, Jie Zhu · 2003 · Journal of Neuroimmunology
  17. Association between plasma cytokine levels and multiple neuroimaging modalities in mild cognitive impairment
    Atsuhito Nakamichi, Noriyuki Kimura, Takuya Hanaoka, Teruaki Masuda, Takuya Ataka, Etsuro Matsubara · 2025 · Journal of Alzheimer s Disease
  18. Skin and Induced Pluripotent Stem Cells as Biomarkers for Neurodegenerative Diseases
    Efstathios Andreas Rallis, Vasiliki-Sofia Grech, Kleomenis Lotsaris, Νiki Tertipi, Εleni Sfyri, Vassiliki Kefala · 2024 · Genes
  19. Common Pathways to Neurodegeneration and Co-morbid Depression
    Darcy Litteljohn, Emily N. Mangano, Shawn P. Hayley · 2010 · Springer eBooks
  20. The effects of intracellular iron availability on the outcome of Toxoplasma gondii infection in mice
    Eman Mostafa, Faten Al-Sayed Mohammed Sayed Ahmed, Samah Hassan Yahia, Alia Ibrahim Mohamed Ibrahim, Enas Said Elbahaie · 2023 · Journal of Parasitic Diseases
  21. Genetic and Blood Biomarkers of Alzheimer`s Disease
    Parastoo Momeni, Raffaele Ferrari · 2010 · The Open Nuclear Medicine Journal
  22. Immunodepressed Status of Mice after Bulbectomy
    Elena G. Novoselova, Н. В. Бобкова, Olga Valentinovna Glushkova, Oksana A. Sinotova, Vyacheslav B. Ogay, Natalia I. Medvinskaya, Alexander N. Samokhin · 2004 · Biology Bulletin
  23. Mendelian randomization and transcriptomic analysis reveal a positive cause-and-effect relationship between Alzheimer's disease and colorectal cancer
    Wei Du, Xueming Xia, Qiheng Gou, Yan Qiu · 2024 · Translational Oncology
  24. Peripheral Markers of Alzheimer’s
    Maire E. Percy, David F. Andrews, Huntington Potter · 2000 · Humana Press eBooks
  25. Microglial Deletion of Hrh4 Alleviates Alzheimer's Disease Pathologies by Enhancing Microglial Phagocytosis of Amyloid‐β and Tau
    Yijun Xu, Tan Wu, Larry Tso‐Lun Lo, Chi‐Chiu Ko, Xin Wang, Chi Him Eddie Ma · 2025 · Advanced Science
  26. Neopterin Levels and Immune Activation in the Blood of Children with Down’s Syndrome
    Federico Licastro, Martina Chiappelli, Elisa Porcellini, M. Rustica, M.M. Corsi · 2005 · Pteridines
  27. Histamine: The Missing Link in the Pathogenesis of Some Brain Disorders
    Ramón Cacabelos · 2016
  28. 19/20 kDa low molecular weight serum protein pattern: a novel potential biochemical prognostic marker for different types of dementia
    Valter Lombardi, Ramón Cacabelos · 1999 · Neuroscience Letters
  29. Serum miR-124 and TNF-α are Biomarkers of Ischemic Cerebrovascular Disease
    Jiajie Liu, Xing‐Hua Liao, Nan Wang, Jun Zhou, Lian Duan, Da‐Lin Lu, Zhipeng Liu, Tingbao Yan, De-Yun Ma, Xiumei Dong et al. · 2013 · Lecture notes in electrical engineering
  30. Anapsos Improves Learning and Memory in Rats with βA(1–28) Deposits Into the Hippocampus
    Antón Álvarez, José Javier Miguel-Hidalgo, L. Fernández‐Novoa, Joaquín Díaz, Jose Miguel Sempere, Ramón Cacabelos · 1998 · Advances in behavioral biology
  31. A Proline−Rich Polypeptide Complex - Its Influence on Cytokine Induction in the Blood of Alzheimer's Patients Kompleks polipeptydowy bogaty w prolinę - wpływ na indukcję cytokin we krwi chorych na chorobę Alzheimera
    Jerzy Leszek, Maria Janusz · 2006
  32. Neuropathology of Post-stroke Depression: Possible Role of Inflammatory Molecules and Indoleamine 2,3-dioxygenase
    Amy P. Wong · 2010 · TSpace (University of Toronto)
  33. CSF TNF-α Levels Were Associated with Longitudinal Change in Brain Glucose Metabolism Among Non-Demented Older People
    Pan Fu, Bihong Zhu, Yangping Huang · 2021 · Neuropsychiatric Disease and Treatment
  34. Muscle aging and inflammation
    Ana Maria Teixeira · 2007 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  35. Inflammatory markers associated with dementia: a systematic review and meta-analysis
    J.K. Kuring, J.L. Mathias, L. Ward, G. Tachas · 2026 · Journal of Psychiatric Research
  36. Impact de l’infection à Helicobacter pylori sur la maladie d’Alzheimer
    Claire Roubaud Baudron · 2014 · theses.fr (ABES)
  37. Inhibition of Soluble TNF Mitigates Traumatic Brain Injury as a Risk Factor for the Development of Amyloidogenic Proteins and Functional Deficits in 3xTg-AD Mice.
    Chelsie N. Poffenberger, M. Taylor, Katelyn Larson, E. Mufson, Kirsty Dixon · 2026 · Journal of Neurotrauma
  38. Cytokine dysregulation and hippocampal neurogenesis: A shared mechanism underlying cognitive impairments across neuropsychiatric and neurodegenerative disorders
    Nuriza Tukiran, Theresa Kolb, Lucia Maggioni, Sparsha Rai, Zain Rafath, Alessandra Borsini · 2026 · Brain Behavior and Immunity
  39. Untitled work
    Jonnal · 2000 · 10.1002/1096-8628(20001204)96:6